Abstract: Disclosed herein are methods, kits, systems, algorithms and improvements for detecting the presence of or determining an amount, quantity, concentration and/or level of an antibody against at least one type of ?-coronavirus, such as, for example, an antibody against SARS-CoV or SARS-CoV-2, in one or more samples obtained from a subject. In some aspects, the methods, kits and systems relate to detecting the presence of or determining an amount, quantity, concentration and/or level of at least one type of anti-?-coronavirus antibody, such as an IgG and/or IgM antibody, in one or more samples obtained from a subject.

Abstract: The present disclosure provides detection methods employing HCV core lipid binding domain and DNA binding domain monoclonal antibodies. In certain embodiments, the lipid binding domain monoclonal antibody recognizes an epitope in amino acids 141 to 161 of HCV core protein.

Abstract: The present disclosure provides detection methods employing HCV core lipid binding domain and DNA binding domain monoclonal antibodies. In certain embodiments, the lipid binding domain monoclonal antibody recognizes an epitope in amino acids 141 to 161 of HCV core protein.

Abstract: The present disclosure provides detection methods employing HCV core lipid binding domain and DNA binding domain monoclonal antibodies. In certain embodiments, the lipid binding domain monoclonal antibody recognizes an epitope in amino acids 141 to 161 of HCV core protein.

Abstract: The present disclosure provides detection methods employing HCV core lipid binding domain and DNA binding domain monoclonal antibodies or antibody fragments. In certain embodiments, the lipid binding domain monoclonal antibody or antibody fragment recognizes an epitope in amino acids 141 to 161 of HCV core protein and the DNA binding domain antibody or antibody fragment recognizes an epitope in amino acids 95-123 (e.g., in amino acids 99-117) of HCV core protein.

Abstract: The present disclosure provides detection methods employing HCV core lipid binding domain and DNA binding domain monoclonal antibodies or antibody fragments. In certain embodiments, the lipid binding domain monoclonal antibody or antibody fragment recognizes an epitope in amino acids 141 to 161 of HCV core protein and the DNA binding domain antibody or antibody fragment recognizes an epitope in amino acids 95-123 (e.g., in amino acids 99-117) of HCV core protein.

Abstract: The present disclosure provides detection methods employing HCV core lipid binding domain and DNA binding domain monoclonal antibodies. In certain embodiments, the lipid binding domain monoclonal antibody recognizes an epitope in amino acids 141 to 161 of HCV core protein.

Abstract: The present invention relates to monoclonal antibodies for the detection of HCV antigen. More specifically, the invention describes antibodies against HCV core antigen lipid binding domain and immunoassay methods, kits and compositions for use in detecting HCV infection.

Abstract: The present disclosure provides detection methods employing HCV core lipid binding domain and DNA binding domain monoclonal antibodies. In certain embodiments, the lipid binding domain monoclonal antibody recognizes an epitope in amino acids 141 to 161 of HCV core protein.

Abstract: The present disclosure provides detection methods employing HCV core lipid binding domain and DNA binding domain monoclonal antibodies or antibody fragments. In certain embodiments, the lipid binding domain monoclonal antibody or antibody fragment recognizes an epitope in amino acids 141 to 161 of HCV core protein and the DNA binding domain antibody or antibody fragment recognizes an epitope in amino acids 95-123 (e.g., in amino acids 99-117) of HCV core protein.

Abstract: The present invention relates to monoclonal antibodies for the detection of HCV antigen. More specifically, the invention describes antibodies against HCV core antigen lipid binding domain and immunoassay methods, kits and compositions for use in detecting HCV infection.

Abstract: The present invention relates to monoclonal antibodies for the detection of HCV antigen. More specifically, the invention describes antibodies against HCV core antigen lipid binding domain and immunoassay methods, kits and compositions for use in detecting HCV infection.

Abstract: The present invention relates to monoclonal antibodies for the detection of HCV antigen. More specifically, the invention describes antibodies against HCV core antigen lipid binding domain and immunoassay methods, kits and compositions for use in detecting HCV infection.

Abstract: Described herein are systems and methods for dynamic project management and capacity management. Specifically, the systems and method include a management tool for performing project management, capacity management, and time and cost creation across systems and departments for the lowest levels of data. The management tool include a computer readable storage medium including a set of instructions that are executable by a processor, the set of instructions being operable to store projected time information and projected cost information for a project, store actual time information and actual cost information for the project, and display a correlation between i) the projected time information and actual time information, and ii) the projected cost information and the actual cost information.

Abstract: Described herein are systems and methods for dynamic project management and capacity management. Specifically, the systems and method include a management tool for performing project management, capacity management, and time and cost creation across systems and departments for the lowest levels of data. The management tool include a computer readable storage medium including a set of instructions that are executable by a processor, the set of instructions being operable to store projected time information and projected cost information for a project, store actual time information and actual cost information for the project, and display a correlation between i) the projected time information and actual time information, and ii) the projected cost information and the actual cost information.

Abstract: A system for providing expanded emergency communication in a telecommunication network including an array of switches, junctions, channels, customer-operated communication devices and service providing stations. The network is connected to facilitate communication among stations using a plurality of milieux. Communication is effected among a service providing station, an emergency complex, an emergency answering position, and an expanded service subscriber. The system comprises: (a) a request acquisition subsystem for receiving emergency requests from a requesting caller; (b) an information store for storing information relating to selected callers; (c) a notification facility for notifying selected subscribers; and (d) a dispatch facility for receiving selected of the information relating to an extant emergency. The system effects transfer of information from the information store to the dispatch facility based upon emergency request information relating to the extant emergency.

Abstract: A system for handling special number calls in a telecommunication network. The network includes an array of switches, junctions, communication channels, customer-operated communication devices and telecommunication service providing stations connected to facilitate communication among a plurality of stations using a plurality of communication milieux. The system comprises: (a) at least one special number call processing center connected with the network; (b) at least one special number answering station connected with the special number call processing center; and (c) at least one special number action station connected with the special number answering station. The special number action station is configured for selective connection with a plurality of action agencies. Selected of the telecommunication service providing stations are connected with at least one of the at least one special number processing center.

Abstract: A system for handling special number calls in a telecommunication network. The network includes an array of switches, junctions, communication channels, customer-operated communication devices and telecommunication service providing stations connected to facilitate communication among a plurality of stations using a plurality of communication milieux. The system comprises: (a) at least one special number call processing center connected with the network; (b) at least one special number answering station connected with the special number call processing center; and (c) at least one special number action station connected with the special number answering station. The special number action station is configured for selective connection with a plurality of action agencies. Selected of the telecommunication service providing stations are connected with at least one of the at least one special number processing center.

Abstract: Emergency service calls, such as 911 calls, are routed to specially trained operators at public service answering points (PSAPs). A PSAP switch, a special focus private branch exchange (PBX), is provided for interconnecting incoming PSAP calls to a PSAP position staffed by a PSAP operator. The PSAP position comprises a telephone facility for talking to the caller, and a PC for accessing and displaying data about the caller, i.e., the caller's address, and any special characteristics such as a caller's disability, etc. An ISDN, (Integrated Services Digital Network), line connects a tandem access switch used for routing PSAP calls with the PSAP switch. The ISDN facility is used for conveying information about the caller for display at the PC of the answering PSAP position. Advantageously, this arrangement provides an integrated system for communicating both the voice of the caller, and the data describing the caller to a PSAP operator.